Honeycomb Biotechnologies
PrivateLast Round
Grant
Mar 1, 2023
Total Funding Raised
$1.88M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Honeycomb Biotechnologies operates in Healthcare & Life Sciences and is based in Waltham, Massachusetts. Its latest recorded funding round was a Grant round in March 2023.
Honeycomb Biotechnologies is a biotechnology company that develops instrument-free single-cell analysis solutions for clinical and basic research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Honeycomb Biotechnologies Comparables
Compare Honeycomb Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Illumina, Inc. | 85% | |
| Singleron Biotechnologies | 77% | |
| MobiDrop Biotech | 74% |
For institutional investors. Book with your work email.
Honeycomb Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2023 | ||||
| Grant | Mar 1, 2022 | ||||
| Grant | Mar 1, 2021 | ||||
| Grant | Sep 20, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Honeycomb Biotechnologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Massachusetts Development Finance Agency | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors increased 260% MoM, reaching 2.8K.
- Aug 20, 2026
Monthly visitors grew 100% MoM.
For institutional investors. Book with your work email.
Honeycomb Biotechnologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Honeycomb Biotechnologies's valuation, stock price, and market status.
Is Honeycomb Biotechnologies a public or private company?
Honeycomb Biotechnologies is a private company.
What is the current stock price of Honeycomb Biotechnologies?
Honeycomb Biotechnologies is a private company, so its shares have no public market price. Caplight tracks Honeycomb Biotechnologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Honeycomb Biotechnologies worth (valuation)?
Valuation information for Honeycomb Biotechnologies is not publicly available.
Can I buy Honeycomb Biotechnologies stock?
Honeycomb Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Honeycomb Biotechnologies's last funding round?
Honeycomb Biotechnologies's most recent funding round was Grant on March 1, 2023.
Who are the main investors in Honeycomb Biotechnologies?
Key investors in Honeycomb Biotechnologies include NIH RADx, Massachusetts Development Finance Agency.
Will Honeycomb Biotechnologies IPO soon?
No public IPO plans have been announced for Honeycomb Biotechnologies.
How can I track Honeycomb Biotechnologies secondary market activity?
Caplight tracks bids, offers, and trades in Honeycomb Biotechnologies's shares on secondary markets.